Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Nanobiotix S.A., a foreign private issuer, covers the reporting period of December 1, 2025. The document serves as a notification of transactions by Persons Discharging Managerial Responsibilities (PDMR) and persons closely associated with them, in compliance with the EU Market Abuse Regulation (MAR).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a regulatory disclosure of insider transactions and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial performance or business operations are reported in this document. The filing solely discloses the occurrence of PDMR transactions as required by law.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a procedural filing regarding compliance with the EU Market Abuse Regulation.
Key Facts for Investor Verification
- The filing discloses PDMR transactions but does not include the specific details of the trades (e.g., volume, price) within the main text; these are referenced in Exhibit 99.1.
- Exhibit 99.1 contains the PDMR notifications in French.
- The report was signed by Laurent Levy, Chairman of the Executive Board, on December 1, 2025.